Isotretinoin and risk of inflammatory bowel disease

American Journal of Gastroenterology

Volumn 109, Issue 9, 2014, Pages 1493-1494

  Dai, Cong ^a   Jiang, Min ^a   Sun, Ming Jun ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN; DERMATOLOGICAL AGENT;

ACNE; CROHN DISEASE; HUMAN; LETTER; NATURAL KILLER CELL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; RARE DISEASE; REGULATORY T LYMPHOCYTE; RISK FACTOR; ULCERATIVE COLITIS; CHEMICALLY INDUCED DISORDER; FEMALE; MALE; NOTE;

COLITIS, ULCERATIVE; CROHN DISEASE; DERMATOLOGIC AGENTS; FEMALE; HUMANS; ISOTRETINOIN; MALE;

EID: 84908241539     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2014.184     Document Type: Letter

References (4)

1. Racine A, Cuerq A, Bijon A, et al. Isotretinoin and risk of infl ammatory bowel disease: a French Nationwide Study. Am J Gastroenterol 2014; 109: 563-9.
2. Femia AN, Ann Vleugels R. Toward improved understanding of a potential association between isotretinoin and infl ammatory bowel disease. J Invest Dermatol 2013; 133: 866-8.
3. Papageorgiou NP, Altman A, Shoenfeld Y. Infl ammatory bowel disease: adverse effect of isotretinoin. Isr Med Assoc J 2009; 11: 505-6.
4. Reddy D, Siegel CA, Sands BE, et al. Possible association between isotretinoin and infl ammatory bowel disease. Am J Gastroenterol 2006; 101: 1569-73.